Skip to main content
. 2023 Sep 12;23(8):5183–5190. doi: 10.1007/s10238-023-01187-x

Table 2.

Place of death, cause of death ad hospital interaction stratified by mortality

30 days (n = 50) 31–60 days (n = 41) p-value
n % n %
Cause of death
Infection 5 10.0 2 4.9 0.45
Cardiac arrest 4 8.0 1 2.4 1.00
Paraneoplastic 2 4.0 1 2.4 1.00
Tumor progression 24 48.0 21 42.0 0.92
 Tumor mass 9 18.0 14 28.0 0.13
 Thoracic 9 18.0 6 14.6 0.88
 Brain 6 12.0 1 2.4 0.12
Respiratory 3 6.0 1 2.4 0.62
Complication from therapy 9 18.0 6 14.6 0.88
 Chemotherapy 1 2.0 2 4.9 0.59
 Radiotherapy 1 2.0 0 0.0 1.00
 Intraoperative 7 14.0 4 9.8 0.51
Thrombosis 1 2.0 0 0.0 1.00
Unexpected after discharge 4 8.0 7 17.1 0.21
Unknown 1 2.0 2 4.9 0.59
Place of death
Acute setting 37 74.0 17 41.5 0.003
 Intensive or intermediate care 13 26.0 5 12.2 0.16
 General ward 24 48.0 12 29.3 0.11
Non-acute setting 9 18.0 15 36.6 0.08
 Palliative ward 7 14.0 10 24.4 0.32
 At home/nursing home 2 4.0 5 12.2 0.24
Unknown 4 8.0 9 22.0 0.11
Previous hospital interaction
Palliative team involved 15 30.0 19 46.3 0.17
Admission to emergency room 15 30.0 14 34.1 0.84
Intensive or intermediate care stay 21 42.0 6 14.6 0.01

Comparison of place of death and cause of death, and hospital interaction of subgroup of patients with 30 and 60-day-mortality. P-values of group comparison from Chi2-test